Evans sydrome: Successful management with multi-agent treatment including intermediate-dose intravenous cyclophosphamide [1]

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 3, 1999, Pages 248-249

  Gombakis, N ^a   Trahana, M ^a   Athanassiou, M ^a   Kanakoudi Tsakalidou, F ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; MAINTENANCE THERAPY; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; TREATMENT OUTCOME; CHILD; DRUG COMBINATION; NOTE; SPLENECTOMY; SYNDROME;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTI-INFLAMMATORY AGENTS; CHILD; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; SYNDROME;

EID: 0033238065     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199905000-00016     Document Type: Letter

References (4)